Roche (USOTC:RHHBY) has secured exclusive worldwide rights to Rona Therapeutics’ investigational ALK7-targeting RNA ...

Scientists have long used a powerful gene-editing tool called CRISPR to make precise changes to DNA. But a different version ...

MONTREAL--(BUSINESS WIRE)--AmorChem II Fund L.P. (''AmorChem'') is delighted to announce that its RNA Zipcode delivery program has been acquired by Kodikaz Therapeutic Solutions, Inc. (''Kodikaz''), a ...

DelveInsight's RNAi Technology Market Insights report provides the current and forecast market analysis, individual leading RNAi technology companies' market shares, challenges, RNAi technology market ...

Actionable insights reveal new revenue streams, growth opportunities, competitive strategies, and regional trends to guide smarter RNAi investments.Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- "RNAi ...

Novartis (NYSE:NVS) has entered into a licensing agreement with Chinese biotechnology company Abogen covering an experimental RNA-based therapy and other potential treatments developed using Abogen’s ...

BOSTON, Jan. 14, 2025 /PRNewswire/ -- Keylicon Biosciences is pleased to announce its exclusive rights to a groundbreaking next-generation RNA technology developed at ...

As the science behind a novel approach to treating disease evolves, the focus of research and clinical development is ...

RNA interference – RNAi – functions specifically to silence, or deactivate, genes. Among other applications, it promises to be groundbreaking as a way to treat infections of bees by a commercially ...

When a neuron in our body gets damaged, segments of RNA produce proteins that can help repair the injury. But in neurological disorders such as ALS and spinal muscular atrophy, or following spinal ...

A chemical-free method of controlling flystrike in sheep is a step closer, according to University of Queensland research. Queensland Alliance for Agriculture and Food Innovation Research Fellow Dr.